Search results
Regular tests can spot trends in PSA blood levels, which could be a sign of prostate cancer developing, particularly if you have an increased risk. So should I have a PSA blood test or not? It can help find aggressive prostate cancers early – when treatments are more likely to cure the cancer.
A raised PSA level can be a sign of prostate cancer but can also occur due to a non-cancerous enlargement or inflammation of the prostate.4 Many men have a raised PSA level without having cancer (that is, false positive results). Conversely, a substantial number of men with a low PSA level will subsequently be diagnosed with prostate cancer ...
The post-test probability of chronic pancreatic disease is markedly influenced by the clinical history, physical examination, etiologic risk factor profile, and results of radiologic and endoscopic imaging tests.
Chronic pancreatitis (CP) is defined according to the recently proposed mechanistic definition as a pathological fibro-inflammatory syndrome of the pancreas in individuals with genetic, environmental, and/or other risk factors who develop persistent ...
The prostate-specific antigen (PSA) test, introduced in the late 1980s and early 1990s, provides an easy and inexpensive method to identify asymptomatic men who might harbour prostate cancer at an earlier stage, thereby increasing the chances of cure and ultimately reducing prostate cancer–specific mortality [2].
Patients with chronic pancreatitis should be seen at least once a year and re-evaluated for causal risk factors, symptom control, and complications such as malnutrition, pancreatic exocrine insufficiency, and diabetes; refer to a specialised centre if symptoms are poorly controlled or there is risk of deterioration.
Abstract. Background: Chronic pancreatitis (CP) is a complex inflammatory disease with remarkably impaired quality of life and permanent damage of the pancreas. This paper is part of the international consensus guidelines on CP and presents the consensus on factors elevating the risk for CP.
